Zilico was founded in 2006 following a successful collaboration between the University of Sheffield and Sheffield Teaching Hospitals NHS Foundation Trust, UK, to develop a more accurate means of diagnosis for cervical intraepithelial neoplasia (CIN).
The company has developed its patented Electrical Impedance Spectroscopy (EIS) into a platform technology for cancer diagnosis and is expanding its product development into other clinical areas.
ZedScan is a diagnostic system that is used alongside colposcopy to provide an objective assessment of the cervical epithelial tissue in real time.
Clinical Benefits of Using ZedScan
When used alongside colposcopy ZedScan has demonstrated greater accuracy in detecting cervical disease.
Pin-point the location of pre-cancerous lesions
The list of attendees is below:
Ann Marie Sanderson